Giaconi said, The VA in Los Angeles recently made a GLP-1 formulary switch to semaglutide, which is great for glycemic control, but it worsens existing diabetic retinopathy
Ozempic (semaglutide for type 2 diabetes) comes in multi-dose pens with different strengths: 2 mg/1.5 mL pen (delivers 0.25 mg or 0.5 mg doses) 4 mg/3 mL pen (delivers 1 mg doses) 8 mg/3 mL pen (delivers 2 mg doses) Each pen contains multiple doses and is designed to deliver specific dose increments only
To strengthen your claim, be prepared to provide: Prescription records showing use of Ozempic, Wegovy, or Mounjaro Medical records indicating diagnosis and treatment of GI issues Doctors notes on symptom progression Emergency room visit records Test results, including gastric emptying studies Out-of-pocket costs and lost income documentation A personal journal detailing how the condition has impacted your daily life Morgan & Morgan can help gather this information and present it effectively
Inform patients of the signs and symptoms of acute kidney injury and instruct them to promptly report any of these signs or symptoms or persistent (or extended) nausea, vomiting, and diarrhea to their healthcare provider [see Warnings and Precautions (5.5)]
The starting dose is 0.25 mg per week
